SCHEMBL7426600

SCHEMBL7426600

N[C@@H](Cc1nc2ccccc2s1)C(=O)N1CCN(CCOCCO)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 10/20 0.46
DRD3 P35462 8/20 0.46
DRD4 P21917 6/20 0.46
HRH1 P35367 6/20 0.45
HRH2 P25021 4/20 0.45
F2 P00734 1/20 0.44
HTR7 P34969 9/20 0.43
HTR1A P08908 7/20 0.43
ADRA2A P08913 3/20 0.43
ADRA2C P18825 3/20 0.43
ADRA1A P35348 3/20 0.43
HTR2B P41595 3/20 0.43
SLC6A2 P23975 2/20 0.43
SIGMAR1 Q99720 1/20 0.43
HTR2A P28223 8/20 0.42
CTSC P53634 1/20 0.41
POLB P06746 1/20 0.40
DRD1 P21728 3/20 0.40
HTR2C P28335 3/20 0.40
ADRA2B P18089 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419443 0.85 DRD2 (0.50) DRD2DRD3DRD4HRH1HRH2
SCHEMBL7425451 0.85 DRD2 (0.47) DRD2DRD3DRD4HRH1HRH2
Bromide SCHEMBL7418493 0.84 DRD2 (0.46) DRD2DRD3DRD4HRH1HRH2
Bromide SCHEMBL7425690 0.84 DRD2 (0.46) DRD2DRD3DRD4HRH1HRH2
Bromide SCHEMBL7425687 0.84 DRD2 (0.46) DRD2DRD3DRD4HRH1HRH2
Bromide SCHEMBL7418489 0.84 DRD2 (0.46) DRD2DRD3DRD4HRH1HRH2
Hydrochloric Acid SCHEMBL7422561 0.82 NPC1 (0.52) DRD2DRD3DRD4F2CTSC
SCHEMBL7426173 0.78 PRMT5 (0.44) DRD2DRD3DRD4HRH1F2
SCHEMBL7443425 0.78 F2 (0.54) F2CTSCKMT2A
SCHEMBL7418322 0.77 MAPT (0.44) F2CTSCKMT2ALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815103-A1 TRYPSIN AND THROMBIN INHIBITORS Novartis AG (CH) 1998-01-07 EP disclosed
WO-1996029327-A1 TRYPSIN AND THROMBIN INHIBITORS NOVARTIS AG (CH) 1996-09-26 WO disclosed